These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31135653)

  • 1. ASCCP President 2019-2020 Vision.
    Stockdale CK
    J Low Genit Tract Dis; 2019 Jul; 23(3):187. PubMed ID: 31135653
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.
    Schiffman M; Wentzensen N; Khan MJ; Castle PE; Chelmow D; Huh WK; Moscicki AB; Stockdale CK; Darragh TM; Silver M; Guido RS
    J Low Genit Tract Dis; 2017 Apr; 21(2):87-90. PubMed ID: 28244885
    [No Abstract]   [Full Text] [Related]  

  • 3. Stage IV Cervical Cancer in a Patient Compliant With Current Management Guidelines for Abnormal Cytology: A Case Report.
    Mazul J; Perkins RB
    J Low Genit Tract Dis; 2017 Oct; 21(4):e40-e41. PubMed ID: 28953130
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers for Cervical Cancer Prevention Programs: The Long and Winding Road From Discovery to Clinical Use.
    Wentzensen N; Silver MI
    J Low Genit Tract Dis; 2016 Jul; 20(3):191-4. PubMed ID: 27243141
    [No Abstract]   [Full Text] [Related]  

  • 5. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
    Fontaine PL; Saslow D; King VJ
    Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical neoplasia guidelines: United States and europe compared.
    Stampler KM; Dunton CJ
    J Low Genit Tract Dis; 2010 Apr; 14(2):142-7. PubMed ID: 20354425
    [No Abstract]   [Full Text] [Related]  

  • 7. An Introduction to the New Journal Forum.
    Perkins RB; Schiffman M; Foster DC
    J Low Genit Tract Dis; 2018 Apr; 22(2):89-90. PubMed ID: 29570562
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical cytology screening programs: similarities and differences between the United States and United Kingdom systems.
    Wilbur DC
    Cancer Cytopathol; 2012 Apr; 120(2):102-4. PubMed ID: 22367853
    [No Abstract]   [Full Text] [Related]  

  • 9. The New ASCCP Colposcopy Standards.
    Wright TC
    J Low Genit Tract Dis; 2017 Oct; 21(4):215. PubMed ID: 28953108
    [No Abstract]   [Full Text] [Related]  

  • 10. Practice improvement in cervical screening and management: symposium on management of cervical abnormalities in adolescents and young women.
    Castle PE; Carreon JD
    J Low Genit Tract Dis; 2010 Jul; 14(3):238-340; author reply 240. PubMed ID: 20592562
    [No Abstract]   [Full Text] [Related]  

  • 11. [New guidelines in regard to cervical cancer screening].
    Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
    Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
    Tota JE; Bentley J; Blake J; Coutlée F; Duggan MA; Ferenczy A; Franco EL; Fung-Kee-Fung M; Gotlieb W; Mayrand MH; McLachlin M; Murphy J; Ogilvie G; Ratnam S
    Prev Med; 2017 May; 98():5-14. PubMed ID: 28279264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
    Sundström K; Elfström KM
    PLoS Med; 2020 Jan; 17(1):e1003035. PubMed ID: 31990905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
    Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
    J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting.
    Lamere BJ; Castle PE; Fetterman B; Poitras N; Stanley M; Shieh J; Lorey T; Kinney W; Schiffman M
    J Virol Methods; 2013 Apr; 189(1):77-9. PubMed ID: 23384678
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for cervical cancer: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2012 Sep; 86(6):555-9. PubMed ID: 23062047
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.
    Wentzensen N; Massad LS; Mayeaux EJ; Khan MJ; Waxman AG; Einstein MH; Conageski C; Schiffman MH; Gold MA; Apgar BS; Chelmow D; Choma KK; Darragh TM; Gage JC; Garcia FAR; Guido RS; Jeronimo JA; Liu A; Mathews CA; Mitchell MM; Moscicki AB; Novetsky AP; Papasozomenos T; Perkins RB; Silver MI; Smith KM; Stier EA; Tedeschi CA; Werner CL; Huh WK
    J Low Genit Tract Dis; 2017 Oct; 21(4):216-222. PubMed ID: 28953109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [I. Screening of uterine cervical neoplasms and HPV vaccine].
    Konno R
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):165-9. PubMed ID: 23476961
    [No Abstract]   [Full Text] [Related]  

  • 19. Cervical cancer screening.
    Partridge EE; Abu-Rustum NR; Campos SM; Fahey PJ; Farmer M; Garcia RL; Giuliano A; Jones HW; Lele SM; Lieberman RW; Massad SL; Morgan MA; Reynolds RK; Rhodes HE; Singh DK; Smith-McCune K; Teng N; Trimble CL; Valea F; Wilczynski S;
    J Natl Compr Canc Netw; 2010 Dec; 8(12):1358-86. PubMed ID: 21147902
    [No Abstract]   [Full Text] [Related]  

  • 20. ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States.
    Mayeaux EJ; Novetsky AP; Chelmow D; Garcia F; Choma K; Liu AH; Papasozomenos T; Einstein MH; Massad LS; Wentzensen N; Waxman AG; Conageski C; Khan MJ; Huh WK
    J Low Genit Tract Dis; 2017 Oct; 21(4):242-248. PubMed ID: 28953113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.